Literature DB >> 6404691

Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.

M Miranda, D Botti.   

Abstract

1. Harding-Passey mouse-melanoma tyrosinase (EC 1.14.18.1) is inhibited during L-3,4-dihydroxyphenylalanine oxidation by reaction products. L-3,4-dihydroxyphenyl 3-[14C]alanine oxidation products bind to the enzyme, as demonstrated by gel electrophoresis and radioactivity measurements. 2. The enzyme interacts with indoles and oxidizes dopamine and norepinephrine. 3. L-epinephrine activates tyrosinase at non hormonal concentrations and bovine serum albumin protects the enzyme from auto-inhibition. 4. The inhibition of the Harding-Passey mouse-melanoma tyrosinase, during substrate oxidation, is very similar to that of mushroom enzyme.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404691     DOI: 10.1016/0306-3623(83)90002-2

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  6 in total

1.  Possible genotoxicity of melanin synthesis intermediates: tyrosinase reaction products interact with DNA in vitro.

Authors:  M Miranda; D Botti; M Di Cola
Journal:  Mol Gen Genet       Date:  1984

2.  Neuroprotective effects of 3α-acetoxyeudesma-1,4(15),11(13)-trien-12,6α-olide against dopamine-induced apoptosis in the human neuroblastoma SH-SY5Y cell line.

Authors:  Uk Koo; Kung-Woo Nam; Ahrom Ham; Dahyun Lyu; Bora Kim; Sung-Jin Lee; Kyeong Ho Kim; Ki-Bong Oh; Woongchon Mar; Jongheon Shin
Journal:  Neurochem Res       Date:  2011-06-18       Impact factor: 3.996

Review 3.  Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.

Authors:  Masato Asanuma; Ikuko Miyazaki; Norio Ogawa
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 4.  Tyrosinase-expressing neuronal cell line as in vitro model of Parkinson's disease.

Authors:  Takafumi Hasegawa
Journal:  Int J Mol Sci       Date:  2010-03-12       Impact factor: 5.923

Review 5.  Approaches to prevent dopamine quinone-induced neurotoxicity.

Authors:  Ikuko Miyazaki; Masato Asanuma
Journal:  Neurochem Res       Date:  2008-09-04       Impact factor: 3.996

6.  Transplantation of melanocytes obtained from the skin ameliorates apomorphine-induced abnormal behavior in rodent hemi-parkinsonian models.

Authors:  Masato Asanuma; Ikuko Miyazaki; Francisco J Diaz-Corrales; Youichirou Higashi; Masayoshi Namba; Norio Ogawa
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.